RLBBX
Price
$37.18
Change
+$0.10 (+0.27%)
Updated
Aug 26 closing price
Net Assets
255.46B
RLBCX
Price
$37.28
Change
+$0.11 (+0.30%)
Updated
Aug 26 closing price
Net Assets
255.46B
Interact to see
Advertisement

RLBBX vs RLBCX

Header iconRLBBX vs RLBCX Comparison
Open Charts RLBBX vs RLBCXBanner chart's image
American Funds American Balanced R2
Price$37.18
Change+$0.10 (+0.27%)
VolumeN/A
Net Assets255.46B
American Funds American Balanced R3
Price$37.28
Change+$0.11 (+0.30%)
VolumeN/A
Net Assets255.46B
RLBBX vs RLBCX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
RLBBX vs. RLBCX commentary
Aug 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is RLBBX is a Buy and RLBCX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBBX (255B) and RLBCX (255B) have equal amount of cash in the bank . RLBCX pays higher dividends than RLBBX: RLBCX (1.56) vs RLBBX (1.16). RLBBX was incepted earlier than RLBCX: RLBBX (23 years) vs RLBCX (23 years). RLBBX (1.32) is less costly to investors than RLBCX (0.89). RLBBX (44.00) and RLBCX (44.00) have comparable annual turnover. RLBBX (250) and RLBCX (250) have matching initial minimum investment requirements. RLBCX annual gain was more profitable for investors over the last year : 6.90 vs. RLBBX (6.40). RLBCX return over 5 years is better than : 35.32 vs. RLBBX (32.86).
RLBBXRLBCXRLBBX / RLBCX
Total Expense Ratio1.320.89148%
Annual Report Gross Expense Ratio1.320.89148%
Fund Existence23 years23 years-
Gain YTD9.4709.80297%
Front LoadN/AN/A-
Min. Initial Investment250250100%
Min. Initial Investment IRAN/AN/A-
Net Assets255B255B100%
Annual Yield % from dividends1.161.5675%
Returns for 1 year6.406.9093%
Returns for 3 years31.6433.1895%
Returns for 5 years32.8635.3293%
Returns for 10 years64.7769.0494%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
XFOR4.580.61
+15.37%
X4 Pharmaceuticals Inc
CLDI1.700.14
+8.97%
Calidi Biotherapeutics
H142.390.95
+0.67%
Hyatt Hotels Corp
DBD62.800.10
+0.16%
Diebold Nixdorf
CCSI26.05-0.15
-0.57%
Consensus Cloud Solutions